Pharmaceutical
| Thu 11 Jun 2026
Taipei, June 11 -- Tyligand Bioscience (Shanghai) has submitted a patent application for RAS Inhibitors. This invention was developed by Shang Er-chang, Zhong Boyu, Zhang Tony Yantao, Song Guang-lin, Jiang Jun, Wang Long-fei, Hou Fu-liang, Wang Ji-fa, Wang Heng, Zheng Ai-jun and Dong Chun-lan.
The patent application number is..